A chemotherapy injection that a distributor said could be procured for ₹11,000 was reportedly billed at a hospital for ₹1.3 lakh, prompting the Supreme Court to question steep markups on cancer medicines and medical consumables. The court has sought answers from the Centre and private hospitals over pricing practices and whether such high margins can be justified by hospital operating costs.